Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NYXH

Nyxoah SA

Feb 06 • 04:00PM ET

4.65

+0.06 1.31 %

Healthcare • Medical Instruments & Supplies • Belgium • NASD

Peers: INSP PODD TNDM IART NVRO ZBH GMED SENS SGHT BFLY

| Held by: BMED

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.48	Insider Own	-	Shs Outstand	37.54M	Perf Week	-2.11%
Market Cap	174.56M	Forward P/E	-	EPS next Y	-2.44	Insider Trans	-	Shs Float	24.11M	Perf Month	-7.19%
Enterprise Value	173.01M	PEG	-	EPS next Q	-0.64	Inst Own	24.59%	Short Float	0.93%	Perf Quarter	-6.81%
Income	-92.78M	P/S	27.75	EPS this Y	-26.36%	Inst Trans	-0.90%	Short Ratio	4.97	Perf Half Y	-38.00%
Sales	6.29M	P/B	2.92	EPS next Y	1.77%	ROA	-68.90%	Short Interest	0.22M	Perf YTD	1.09%
Book/sh	1.59	P/C	6.61	EPS next 5Y	4.51%	ROE	-104.99%	52W High	11.87 -60.83%	Perf Year	-57.69%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	-12.56% -34.68%	ROIC	-111.01%	52W Low	4.34 7.02%	Perf 3Y	-16.37%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	69.34% -	Gross Margin	-2.21%	Volatility	2.32% 4.11%	Perf 5Y	-
Dividend TTM	-	EV/Sales	27.51	EPS Y/Y TTM	-33.27%	Oper. Margin	-1478.94%	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.37	Sales Y/Y TTM	14.23%	Profit Margin	-1474.71%	RSI (14)	44.07	Recom	1.44
Dividend Gr. 3/5Y	- -	Current Ratio	1.66	EPS Q/Q	-35.03%	SMA20	-4.13%	Beta	1.59	Target Price	11.06
Payout	-	Debt/Eq	0.42	Sales Q/Q	65.69%	SMA50	-3.14%	Rel Volume	0.22	Prev Close	4.59
Employees	-	LT Debt/Eq	0.40	Earnings	Nov 13 AMC	SMA200	-22.70%	Avg Volume	45.05K	Price	4.65
IPO	Apr 28, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-6.69% 0.63%	Trades		Volume	9,954	Change	1.31%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-23	Initiated	H.C. Wainwright	Buy
Jul-19-23	Initiated	Robert W. Baird	Neutral
Apr-21-22	Initiated	Oppenheimer	Outperform	$30
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$21
Dec-21-21	Resumed	Cantor Fitzgerald	Overweight	$47
Jul-28-21	Initiated	Cantor Fitzgerald	Overweight	$43

Jan-21-26 04:05PM	Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth (GlobeNewswire)
Jan-12-26 04:05PM	Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 (GlobeNewswire)
01:00AM	Publication relating to transparency notification (GlobeNewswire)
Dec-29-25 04:05PM	Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +6.26%
Dec-19-25 04:05PM	Nyxoah Announces Issuance of First Tranche of Convertible Bonds (GlobeNewswire)
01:05AM	Loading…
Dec-17-25 01:05AM	Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Netherlands (GlobeNewswire)
Dec-02-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.42%
Dec-01-25 09:14AM	Nyxoah Gains Favorable CMS Reimbursement Ruling for Genio System (Zacks)
Nov-27-25 04:05PM	Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-26-25 01:45AM	Nyxoah's Genio Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule (GlobeNewswire)
Nov-23-25 08:00PM	Nyxoah SA (NYXH) Q3 2025 Earnings Call Highlights: Strong US Launch and Strategic Expansion ... (GuruFocus.com)
Nov-20-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-13-25 07:30PM	Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio (GlobeNewswire) -9.85% -5.84%
05:55PM	Nyxoah SA (NYXH) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:12PM	Nyxoah Reports Third Quarter 2025 Financial and Operating Results (GlobeNewswire)
07:30AM	Loading…
Nov-12-25 07:30AM	Nyxoah SA (XBRU:NYXH) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-06-25 07:15AM	Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates (Zacks)
Nov-03-25 04:05PM	Nyxoah to Participate in the Stifel 2025 Healthcare Conference (GlobeNewswire)
Oct-30-25 05:10PM	Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 (GlobeNewswire)
10:00AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
Oct-29-25 10:00AM	Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks) +12.41%
Oct-06-25 01:00AM	Nyxoah Announces First U.S. Commercial Patients Implanted with Genio System (GlobeNewswire) +17.17%
Oct-03-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-02-25 09:10AM	Nyxoah Expands in the Middle East to Provide Wider Access to Genio (Zacks)
Sep-23-25 04:10PM	Nyxoah Provides an Update on Expanded Middle East Presence (GlobeNewswire)
Sep-15-25 04:10PM	Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc. (GlobeNewswire) -8.97%
Sep-05-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Sep-02-25 04:30PM	Nyxoah Announces Upcoming Investor Events (GlobeNewswire) -5.45%
Aug-29-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:10PM	Loading…
Aug-18-25 04:10PM	Nyxoah Reports Second Quarter Financial and Operating Results (GlobeNewswire) +5.63%
Aug-15-25 10:10AM	Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea (Zacks) -8.53%
09:18AM	Nyxoah SA (NYXH) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-11-25 07:00PM	Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -5.39%
01:00AM	Nyxoah Announces Preliminary Results for the Second Quarter of 2025 (GlobeNewswire)
Aug-08-25 04:10PM	Nyxoah Receives Approval from FDA for Genio System for the Treatment of Obstructive Sleep Apnea (GlobeNewswire)
Aug-07-25 07:10AM	Privia Health (PRVA) Misses Q2 Earnings Estimates (Zacks)
Aug-06-25 05:55PM	Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
Jul-29-25 04:45PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025 (GlobeNewswire)
Jul-28-25 04:05PM	Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine (GlobeNewswire) -5.41%
Jun-27-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Jun-13-25 01:00AM	Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025 (GlobeNewswire)
May-30-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
May-28-25 04:30PM	Nyxoah to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-23-25 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire) -6.97%
May-14-25 07:35AM	Nyxoah SA (NYXH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
01:00AM	Nyxoah Reports First Quarter Financial and Operating Results (GlobeNewswire)
May-09-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire) -5.08%
01:00AM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025 (GlobeNewswire)
May-08-25 07:15AM	Claritev Corporation (CTEV) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-07-25 05:15PM	Health Catalyst (HCAT) Q1 Earnings Meet Estimates (Zacks)
04:30PM	Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 (GlobeNewswire)
May-06-25 05:55PM	Clover Health Investments, Corp. (CLOV) Surpasses Q1 Earnings Estimates (Zacks)
Apr-16-25 02:00AM	Conditional Issuance of Shares (GlobeNewswire)
Apr-08-25 01:00AM	Nyxoah Provides Update on FDA Approvable Letter for Genio System (GlobeNewswire) +6.13%
Mar-26-25 03:00AM	FDA Issues Nyxoah an Approvable Letter for its Genio System (GlobeNewswire) -21.36%
Mar-13-25 02:00AM	Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results (GlobeNewswire)
Mar-10-25 05:05PM	Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 (GlobeNewswire)
Mar-03-25 04:30PM	Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-19-25 01:05AM	Nyxoah Announces Commercial Launch of Genio Breakthrough Therapy in the Middle East (GlobeNewswire)
Jan-20-25 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Dec-20-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Dec-13-24 02:05AM	Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England (GlobeNewswire)
Nov-27-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Nov-20-24 04:05PM	Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-19-24 01:00AM	Invitation to attend the special shareholders' meeting of the Company to be held on December 19, 2024 (GlobeNewswire)
Nov-18-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Nov-06-24 04:05PM	Nyxoah Reports Third Quarter Financial and Operating Results (GlobeNewswire)
Nov-04-24 04:45PM	Nyxoah Appoints John Landry as Chief Financial Officer (GlobeNewswire) +5.40%
Oct-25-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-22-24 04:30PM	Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-15-24 04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-09-24 04:35PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:30PM	Publication relating to transparency notifications (GlobeNewswire)
Oct-08-24 05:49PM	Nyxoah Secures $27 Million to Boost U.S. Presence (TipRanks)
Oct-07-24 05:00PM	Nyxoah Raises $27 Million through its At-the-Market Offering (GlobeNewswire)
Sep-27-24 04:30PM	DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update (GlobeNewswire) +5.56%
02:05AM	Information on the total number of voting rights and shares (GlobeNewswire)
02:00AM	Publication relating to transparency notifications (GlobeNewswire)
Sep-05-24 04:30PM	Nyxoah to Participate in Upcoming Investor Conferences (GlobeNewswire)
Sep-02-24 04:05PM	Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device (GlobeNewswire)
Aug-06-24 04:05PM	Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results (GlobeNewswire)
Jul-29-24 04:30PM	Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024 (GlobeNewswire)
Jul-15-24 02:00AM	Nyxoah Appoints Scott Holstine as Chief Commercial Officer (GlobeNewswire)
Jul-03-24 06:30AM	Nyxoah Has Signed a 37.5 Million Loan Facility Agreement with the European Investment Bank (GlobeNewswire) +5.27%
Jul-01-24 02:00AM	Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA (GlobeNewswire)
Jun-28-24 04:30PM	Information on the total number of voting rights and shares (GlobeNewswire)
Jun-03-24 04:30PM	Nyxoah to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire) -8.61%
04:15PM	Information on the total number of voting rights and shares (GlobeNewswire)
04:05PM	Publication relating to transparency notifications (GlobeNewswire)
May-31-24 02:00AM	Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares (GlobeNewswire)
May-28-24 04:30PM	Information on the Total Number of Voting Rights and Shares (GlobeNewswire)
May-23-24 09:59AM	Nyxoah Announces Pricing of Offering (GlobeNewswire) -17.69%
May-22-24 04:10PM	Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program (GlobeNewswire)
04:05PM	Nyxoah Announces Proposed Offering of Ordinary Shares (GlobeNewswire)
May-14-24 04:05PM	Nyxoah Reports First Quarter 2024 Financial and Operating Results (GlobeNewswire) +8.25% +7.20%
May-13-24 04:30PM	Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire) +7.53%
May-10-24 01:00AM	Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024 (GlobeNewswire)
Apr-30-24 01:31PM	ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript (Insider Monkey) -6.55%

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). Its solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA. The company was founded by Robert Taub and Adi Mashiach on July 15, 2009, and is headquartered in Mont-Saint-Guibert, Belgium.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NYXH

Nyxoah SA

Upgrade your FINVIZ experience